Cellectar Biosciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Cellectar Biosciences, Inc. (CLRB) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2026-03-04
- Cellectar Biosciences, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2015-03-31 was 0.00%.
- Cellectar Biosciences, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2013-09-30 was 0.00%.
- Cellectar Biosciences, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2013-03-31 was 0.00%.
- Cellectar Biosciences, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2012-09-30 was 0.00%.
- Cellectar Biosciences, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2025 was 0.00%.
- Cellectar Biosciences, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2024 was 0.00%.
- Cellectar Biosciences, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2023 was 0.00%.
- Cellectar Biosciences, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2022 was 0.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month |
|---|---|---|---|---|
| 2025-12-31 | 0.00% 10-K · filed 2026-03-04 | |||
| 2024-12-31 | 0.00% 10-K · filed 2026-03-04 | |||
| 2023-12-31 | 0.00% 10-K · filed 2025-03-13 | |||
| 2022-12-31 | 0.00% 10-K/A · filed 2024-10-29 | |||
| 2021-12-31 | 0.00% 10-K · filed 2023-03-09 | |||
| 2020-12-31 | 0.00% 10-K · filed 2022-03-21 | |||
| 2019-12-31 | 0.00% 10-K · filed 2021-03-02 | |||
| 2018-12-31 | 0.00% 10-K · filed 2020-03-09 | |||
| 2017-12-31 | 0.00% 10-K · filed 2019-02-26 | |||
| 2016-12-31 | 0.00% 10-K · filed 2018-03-21 | |||
| 2016-09-30 | 0.00% 10-Q · filed 2016-11-10 | |||
| 2016-06-30 | 0.00% 10-Q · filed 2016-08-11 | |||
| 2015-12-31 | 0.00% 10-K · filed 2017-03-15 | |||
| 2015-09-30 | 0.00% 10-Q · filed 2016-11-10 | |||
| 2015-06-30 | 0.00% 10-Q · filed 2016-08-11 | |||
| 2015-03-31 | 0.00% 10-Q · filed 2015-05-20 | |||
| 2014-12-31 | 0.00% 10-K/A · filed 2016-10-20 | |||
| 2014-09-30 | 0.00% 10-Q · filed 2015-11-12 | |||
| 2014-06-30 | 0.00% 10-Q · filed 2015-08-12 | |||
| 2013-12-31 | 0.00% 10-K · filed 2015-05-20 | |||
| 2013-09-30 | 0.00% 10-Q · filed 2013-11-13 | 0.00% 10-Q · filed 2015-05-20 | ||
| 2013-06-30 | 0.00% 10-Q · filed 2014-08-04 | |||
| 2013-03-31 | 0.00% 10-Q · filed 2014-05-14 | |||
| 2012-12-31 | 0.00% 10-K · filed 2014-03-19 | |||
| 2012-09-30 | 0.00% 10-Q · filed 2013-11-13 | 0.00% 10-Q · filed 2013-11-13 | ||
| 2011-12-31 | 0.00% 10-K · filed 2013-03-28 | |||
| 2011-09-30 | 0.00% 10-Q · filed 2012-11-06 | |||
| 2011-06-30 | 0.00% 10-Q · filed 2012-08-09 | 0.00% 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |